2023 - Research.com Microbiology in France Leader Award
2017 - Member of Academia Europaea
2012 - ASM Award for Research in Clinical Microbiology, American Society for Microbiology
His primary areas of investigation include Microbiology, Genetics, Plasmid, Drug resistance and Antibacterial agent. The various areas that Patrice Courvalin examines in his Microbiology study include Virology and Escherichia coli. His studies deal with areas such as Citrobacter freundii and Molecular biology as well as Plasmid.
His Drug resistance research includes themes of Mutation, Intensive care and Chloramphenicol. His Antibacterial agent research integrates issues from Lincosamides, Streptococcus pneumoniae, 23S ribosomal RNA, Efflux and Streptococcaceae. His research integrates issues of Gram-negative bacteria and Bacteria in his study of Antibiotics.
His main research concerns Microbiology, Genetics, Plasmid, Gene and Antibacterial agent. His Microbiology study combines topics in areas such as Bacteria and Escherichia coli. His work in Plasmid covers topics such as Molecular biology which are related to areas like Promoter and Gene cluster.
His study in Gene is interdisciplinary in nature, drawing from both Aminoglycoside and Acinetobacter baumannii. His Antibacterial agent study integrates concerns from other disciplines, such as Vancomycin, Teicoplanin, Minimum inhibitory concentration, Glycopeptide and Streptococcaceae. His Glycopeptide research incorporates themes from Peptidoglycan, Enterococcus faecium and Staphylococcus aureus.
His primary scientific interests are in Microbiology, Gene, Genetics, Antibiotic resistance and Drug resistance. His Microbiology research integrates issues from Plasmid, Efflux and Acinetobacter baumannii. His Gene research is multidisciplinary, relying on both Aminoglycoside and DNA.
His research investigates the link between Antibiotic resistance and topics such as Listeria monocytogenes that cross with problems in Trimethoprim. His Drug resistance research is multidisciplinary, incorporating elements of Enterococcus, Beta-lactamase, Antimicrobial and Enterobacter. He has researched Operon in several fields, including Glycopeptide, Molecular biology, Vancomycin and Peptidoglycan.
Patrice Courvalin mainly focuses on Microbiology, Drug resistance, Acinetobacter baumannii, Antibiotic resistance and Genetics. His studies in Microbiology integrate themes in fields like Plasmid, Gene and Efflux. His Plasmid study incorporates themes from Molecular biology, Neisseriaceae and Fusidic acid.
His studies deal with areas such as Meticillin, Virology, Staphylococcus aureus, Glycopeptide and Beta-lactamase as well as Drug resistance. His biological study spans a wide range of topics, including Operon, Mutant and Acinetobacter calcoaceticus, Acinetobacter. His Antibiotic resistance study combines topics from a wide range of disciplines, such as Bacterial genetics, Biotechnology, Listeria monocytogenes and Trimethoprim.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.
Roland Leclercq;Eliane Derlot;Jean Duval;Patrice Courvalin.
The New England Journal of Medicine (1988)
Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.
S Dutka-Malen;S Evers;P Courvalin.
Journal of Clinical Microbiology (1995)
Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.
Marilyn C Roberts;Joyce Sutcliffe;Patrice Courvalin;Lars Bogo Jensen.
Antimicrobial Agents and Chemotherapy (1999)
Tackling antibiotic resistance
Karen Bush;Patrice Courvalin;Gautam Dantas;Julian Davies.
Nature Reviews Microbiology (2011)
Genetics and mechanisms of glycopeptide resistance in enterococci.
M Arthur;P Courvalin.
Antimicrobial Agents and Chemotherapy (1993)
Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA.
Timothy D. H. Bugg;Gerard D. Wright;Sylvie Dutka-Malen;Michel Arthur.
Resistance-Nodulation-Cell Division-Type Efflux Pump Involved in Aminoglycoside Resistance in Acinetobacter baumannii Strain BM4454
Sophie Magnet;Patrice Courvalin;Thierry Lambert.
Antimicrobial Agents and Chemotherapy (2001)
Multidrug resistance in Yersinia pestis mediated by a transferable plasmid
Marc Galimand;Annie Guiyoule;Guy Gerbaud;Bruno Rasoamanana.
The New England Journal of Medicine (1997)
Efflux-Mediated Antibiotic Resistance in Acinetobacter spp.
Sébastien Coyne;Patrice Courvalin;Bruno Périchon.
Antimicrobial Agents and Chemotherapy (2011)
Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006.
Anne Tristan;Michele Bes;Helene Meugnier;Gerard Lina.
Emerging Infectious Diseases (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: